Jian Yi Li
Overview
Explore the profile of Jian Yi Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
467
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jain S, Abdelwahed M, Chavarria D, Pereira L, Stone G, Johnson A, et al.
J Med Case Rep
. 2024 Jan;
18(1):24.
PMID: 38243328
Background: Carcinosarcoma of the parotid gland is an extremely rare malignancy comprising of 0.04-0.16% of all salivary gland tumors. This is the first case of an adenoid cystic carcinoma with...
2.
Cho Y, El Khoury L, Paramo J, Horowitz D, Li J, Kello N
BMC Musculoskelet Disord
. 2023 May;
24(1):382.
PMID: 37189114
Background: Giant Cell Arteritis (GCA) is a large vessel vasculitis that most commonly presents with headache, scalp tenderness, jaw claudication, and vision changes. Various other, less common, manifestations have been...
3.
Zhang D, Yong W, Movassaghi M, Rodriguez F, Yang I, McKeever P, et al.
Biomedicines
. 2022 Nov;
10(11).
PMID: 36359362
Neurocytomas are rare low-grade brain tumors predominantly affecting young adults, but their cellular origin and molecular pathogenesis is largely unknown. We previously reported a sellar neurocytoma that secreted excess arginine...
4.
Ballout A, Babaie A, Kolesnik M, Li J, Hameed N, Waldman G, et al.
Front Neurol
. 2022 Mar;
13:796882.
PMID: 35280277
Background: Since 2020, over 250 million doses of mRNA-based SARS-CoV-2 vaccines have been administered in the United States and hundreds of millions worldwide between the Pfizer-BioNTech and Moderna SARS-CoV-2 vaccines....
5.
Oh H, Hwang I, Jang J, Wu L, Cao D, Yao J, et al.
Cancer Res
. 2021 Jan;
81(6):1528-1539.
PMID: 33509942
EGFR is frequently amplified, mutated, and overexpressed in malignant gliomas. Yet the EGFR-targeted therapies have thus far produced only marginal clinical responses, and the underlying mechanism remains poorly understood. Using...
6.
Roth S, Faquin W, Gimenez C, Vadalia B, Frank D, Li J
Head Neck Pathol
. 2019 Apr;
14(1):166-172.
PMID: 30968284
Schwannoma-like pleomorphic adenoma is a rare variant of the common benign salivary neoplasm, pleomorphic adenoma. This entity's cytomorphology closely mimics a schwannoma, potentially making a diagnosis of cytologic preparations or...
7.
Zhang D, Kim S, Kelly D, Asa S, Movassaghi M, Mareninov S, et al.
J Clin Endocrinol Metab
. 2019 Feb;
104(6):2395-2402.
PMID: 30722009
Context: Neurocytoma (NC) is a rare, low-grade tumor of the central nervous system, with a 10-year survival rate of 90% and local control rate of 74%. However, 25% of NCs...
8.
Xu G, Zheng H, Li J
Brain Tumor Pathol
. 2019 Feb;
36(3):129-134.
PMID: 30715630
Glioblastoma with a primitive neuronal component (GBM-PN) was renamed from glioblastoma with primitive neuroectodermal tumor-like component (GBM-PNET) in the new WHO classification of tumors of the central nervous system in...
9.
Schneider J, Kwan K, Kulason K, Faltings L, Colantonio S, Safir S, et al.
Surg Neurol Int
. 2018 Jun;
9:100.
PMID: 29900030
Background: Amyloidosis encompasses a group of disorders sharing the common feature of intercellular deposition of amyloid protein by several different pathogenetic mechanisms. Primary solitary amyloidosis, or amyloidoma, is a rare...
10.
Xu G, Li J
J Neurooncol
. 2017 Nov;
136(3):445-452.
PMID: 29150788
Glioblastoma with primitive neuroectodermal tumor-like component (GBM-PNET) is a rare variant of glioblastoma, which was renamed as glioblastoma with a primitive neuronal component (GBM-PN) in new WHO classification of tumours...